A61K 38 - Medicinal preparations containing peptides

Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
11/2006
11/02/2006	US20060247167 Stable formulations of peptides
11/02/2006	US20060247166 Eye disease treating agent and method for treating eye disease
11/02/2006	US20060247165 Methods and compositions for encapsulation of cells
11/02/2006	US20060247164 Meltrins
11/02/2006	US20060247163 Methods and compositions for control of fetal growth via modulation of relaxin
11/02/2006	US20060247162 Skin collagen production promoter
11/02/2006	US20060247161 Use of active ingredients for the prophylaxis and/or therapy of viral diseases
11/02/2006	US20060247160 Administering a polypeptide or biologically active fragment; reducing body mass; metabolic-related diseases, hyperlipidemias, atherosclerosis, diabetes, and hypertension
11/02/2006	US20060247159 For treatment of mucin deficiency (dry mouth syndrome, achlorhydria, mucous cysts, oral submucous fibrosis, oral nevi, oral mucosa cancer, maloplakia of the genito-urinary tract, vulvovaginitis, helicobacter plylori infection, ulcers, peptic ulcers, conditions affecting the uterus and appendicitis)
11/02/2006	US20060247158 Therapeutic methods using cyclosporine components
11/02/2006	US20060247157 making side group protected homocysteine by reacting methionine with sodium in ammonia then alkylating the mercapto group such as with tert-butoxycarbonylalkyl protecting group; use as intermediate in synthesis cyclic peptides, particularly oxytocin antagonist peptides
11/02/2006	US20060247156 Use of neuropeptides for ligament, cartilage, and bone healing
11/02/2006	US20060247155 Methods for alleviating deleterious effects of 3-deoxyglucosone
11/02/2006	US20060247154 Concanavalin a, methods of expressing, purifying and characterizing concanavalina, and sensors including the same
11/02/2006	US20060247153 Method of improving learning and memory in mammals
11/02/2006	US20060247152 Substituted fullerenes and their use as inhibitors of cell death
11/02/2006	US20060246547 Nematode-extracted serine protease inhibitors and anticoagulant proteins
11/02/2006	US20060246543 Slim compositions and methods of use thereof
11/02/2006	US20060246537 Multi-step process for the manufacture of therapeutic protein
11/02/2006	US20060246525 Method of screening remedy for heart disease and medicinal composition for treating heart disease
11/02/2006	US20060246517 Epitope protection assay
11/02/2006	US20060246505 Modulation of the synthesis of insulin
11/02/2006	US20060246486 Human signal peptide-containing proteins
11/02/2006	US20060246448 Inhibition of tace or amphiregulin for the modulation of egf receptor signal transactivation
11/02/2006	US20060246442 Using zinc transporter protein-8 to identify modulators for treatment and diagnosis of diabetic disorders
11/02/2006	US20060246422 Methods and compositions for use in spliceosome mediated RNA trans-splicing
11/02/2006	US20060246421 Compounds and methods for inhibiting hepatitis C virus replication
11/02/2006	US20060246162 Antiestrogenic glyceollins suppress human breast and ovarian carcinoma proliferation and tumorigenesis
11/02/2006	US20060246150 Composition and Process for Bone Growth and Repair
11/02/2006	US20060246148 Anti-bacterial, anti-virus, and anti-fungus composition, its preparation and use
11/02/2006	US20060246146 Method of increasing the salivary sialic acid content in a mammal
11/02/2006	US20060246139 lactic acid-glycolic acid copolymer with an adjusted distribution in molecular weight can be used as a biodegradable release-sustaining base material; drug is a luteinizing hormone-releasing hormone, agonist or antagonist
11/02/2006	US20060246138 Polyoxaester suspending vehicles for use with implantable delivery systems
11/02/2006	US20060246125 Proteoliposome for use as gene transfer tool in treatment and diagnosis of cardiomyopathy, type II diabetes, Alzheimer's, Parkinson's diseases; gene therapy
11/02/2006	US20060246123 Oligonucleotide mimetics
11/02/2006	US20060246110 Sustained release pharmaceutical composition
11/02/2006	US20060246105 Coatings on medical implants to guide soft tissue healing
11/02/2006	US20060246104 Stable rgd peptidomimetic composition
11/02/2006	US20060246096 Nanoparticles from biopolymers
11/02/2006	US20060246092 Immunoprotective influenza antigen and its use in vaccination
11/02/2006	US20060246086 Virulence genes and proteins from Brucella melitensis, and their use
11/02/2006	US20060246085 Methods for manipulating satiety
11/02/2006	US20060246074 Use of alpha 1-antichymotrypsin polypeptides, or nucleic acids encoding them, in combination with alpha 1- antitrypsin polypeptides, or nucleic acids encoding them, for treatment and/or prevention of diabetes-associated and/or arterial poorly healing wounds
11/02/2006	US20060246070 Methods and compositions for treating renal cell carcinoma related pathologies
11/02/2006	US20060246068 Polypeptides having a triggering NK activity and biological applications
11/02/2006	US20060246066 Cleavable reagents for specific delivery to disease sites
11/02/2006	US20060246065 Fail molecules and uses thereof
11/02/2006	US20060246064 monoclonal antibodies; treat bone diseases characterized by changes in bone resorption, such as osteoporosis, hypercalcemia, bone loss due to arthritis metastasis, immobilization or periodontal disease, Paget's disease; denosumab
11/02/2006	US20060246057 Treatment or prevention of damage due to radiation exposure
11/02/2006	US20060246054 Bromelain preparation and pharmaceutical composition containing the same
11/02/2006	US20060246053 Frozen and lyophilized compositions for a metalloproteinase fibrinolytic agent (fibrolase or "novel acting thrombolytic agent" (NAT) with buffer of sodium citrate, zinc acetate, and/or calcium acetate; regeneration
11/02/2006	US20060246052 Means for stabilization of thrombin and compositions
11/02/2006	US20060246051 Male reproductive disorders including proliferative disorders of testes
11/02/2006	US20060246050 Catheter Composition and Uses Thereof
11/02/2006	US20060246049 Compositions and methods for enzymatic detachment of bacterial and fungal biofilms
11/02/2006	US20060246048 Elongation of fatty acids(ELF) polypeptides and carrier mixtures administered for prophylaxis of vision defects
11/02/2006	US20060246047 Peptide wirh apoptosis-inhibiting activity
11/02/2006	US20060246046 Modified tridegins, production and use thereof as transglutaminase inihibitors
11/02/2006	US20060246043 Cellular preparation
11/02/2006	US20060246041 Methods and reagents for tissue engineering of cartilage in vitro
11/02/2006	US20060246039 Growth differentiation factor-7
11/02/2006	US20060246035 Methods and products related to treatment and prevention of hepatitis c virus infection
11/02/2006	US20060246034 Interferon-beta composite
11/02/2006	US20060246033 Injectable bulking agent compositions
11/02/2006	US20060246032 Chimeric IL-10
11/02/2006	US20060246031 Use of cxcl6 chemokine in the prevention or repair cartilage defects
11/02/2006	US20060246029 Contacting skin with a peptide manganese complex; L-alanyl-L-histidyl-L-lysine:manganese(II) or L-valyl-L-histidyl-L-lysine:manganese(II)
11/02/2006	US20060246024 Method for stimulating hair follicle cell proliferation
11/02/2006	US20060246008 Process for the formulation of therapeutic protein
11/02/2006	US20060243667 Filtrate composition with a radiation absorber
11/02/2006	EP1717316A1 Interferon-like protein ZCYTO21
11/02/2006	EP1717315A2 Osteoprotegerin binding proteins and receptors
11/02/2006	EP1717314A1 Receptor for modified low-density lipoprotein
11/02/2006	EP1717310A1 Lineage-directed induction of human mesenchymal stem cell differentiation
11/02/2006	EP1717249A1 Peptides containing a cholesterol recognition sequence and their uses
11/02/2006	EP1717247A1 Cyclic peptides binding to the somatostatin receptor
11/02/2006	EP1717246A1 Tnf antagonists and tnf inhibitors comprising the same as the active ingredient
11/02/2006	EP1717244A1 Akt activity specifically inhibiting polypeptide
11/02/2006	EP1717224A1 Peptidyl arginine deiminase type iv inhibitor
11/02/2006	EP1716887A1 Treatment of inclusion body myositis
11/02/2006	EP1716869A1 Drug for preventing or treating heart diseases comprising cd9 gene
11/02/2006	EP1716865A1 Paraoxonase-containing pharmaceutical preparation
11/02/2006	EP1716864A1 Neural regeneration using home bone morphogenetic proteins
11/02/2006	EP1716863A1 T cell immune response inhibitor
11/02/2006	EP1716862A1 Bactericide against streptococcus mutans and streptococcus sobrinus
11/02/2006	EP1716861A2 Inhibitors of proteasomal activity for stimulating bone and hair growth
11/02/2006	EP1716860A1 Preventive and therapeutic agent for chronic obstructive pulmonary disease
11/02/2006	EP1716858A2 Oncolytic virus
11/02/2006	EP1716849A1 Coating of small particles
11/02/2006	EP1716847A1 Bioabsorbable pharmaceutical formulation comprising a PLGA copolymer
11/02/2006	EP1716419A2 Method for the detection of autoantibodies against specific peptides and its use in diagnosis and treatment of pregnancy-loss or infertility.
11/02/2006	EP1716236A2 Antisense oligonucleotides for treating unwanted pigmentation of the skin and hair
11/02/2006	EP1716235A2 Inhibitors of tgf-r signaling for treatment of cns disorders
11/02/2006	EP1716232A2 Acid alpha-glucosidase and fragments thereof
11/02/2006	EP1716227A2 Methods of identifying putative gene products by interspecies sequence comparison and biomolecular sequences uncovered thereby
11/02/2006	EP1716176A2 Cd38 splice variants and uses thereof
11/02/2006	EP1716174A2 Leucine rich repeat containing protein
11/02/2006	EP1716171A1 IDENTIFICATION OF SNPs ASSOCIATED WITH HYPERLIPIDEMIA, DYSLIPIDEMIA AND DEFECTIVE CARBOHYDRATE METABOLISM
11/02/2006	EP1715971A1 Functionalized colloidal metal compositions and methods
11/02/2006	EP1715896A1 Antisense oligonucleotides directed to ribonucleotide reductase r2 and uses thereof in combination therapies for the treatment of cancer

1 ... 1189 1190 1191 1192 1193 1194 1195 1196 1197 1198 1199 1200 1201 1202 1203 1204 1205 1206 1207 1208 1209 ... 3163